Navigation Links
Several Market Access Drivers Provide Attractive Opportunities for Multinational Companies in Saudi Arabia's Pharmaceutical Market
Date:9/9/2013

BURLINGTON, Mass., Sept. 9, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Saudi Arabia's oil-fueled prosperity, growing population, and liberal health spending policies are major drivers of market growth and have generated attractive opportunities for multinational pharmaceutical companies. An expanding network of medical facilities and the requirement for mandatory health insurance have fueled market expansion. The government is also privatizing the healthcare industry and creating more public-private partnership opportunities to spur investment in new medical cities, which will provide improved access to health services.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

The Saudi Arabia Market Access Tracker finds that the Saudi government is equally committed to the strict regulation of both the private and public sectors in order to provide health benefits at an optimal cost. Despite ample market opportunities for multinationals, strict registration, pricing, and drug distribution policies present challenges to market entry.

The findings also reveal that a major attraction for multinationals is that the domestic pharmaceutical industry has not kept pace with the needs of the Saudi market, which is highly dependent on imported drugs, both brands and generics. However, government policies to promote the domestic industry as well as continuing cost-containment activities will pose barriers to multinationals interested in this important Middle East market.

As the largest pharmaceutical market of the Gulf Cooperation Council (GCC), the Saudi market has both local and regional appeal. "Unified drug registration, pricing, and procurement policies among the member states are steadily molding the GCC region into a harmonized common market, as opposed to the individual markets of the past," said Decision Resources Analyst Gilan Megeed, M.P.H. "Many Saudi regulations and guidelines are modeled after those in the European Union, the World Health Organization, and the International Conference on Harmonization. The GCC common market clearly seeks to emulate the success of the EU common market."

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.


'/>"/>
SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Altaire Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 9 lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution sold under several brands
2. ViroPharma To Participate In Several June Healthcare Investor Conferences
3. Several Market Access Barriers Impede Multinational Companies From Easily Accessing Argentinas Pharmaceutical Market But Attractive Opportunities Exist
4. Texas Childrens Hospital is the first childrens hospital in the nation to offer PET/MRI scanner to better diagnose several childhood diseases
5. Medbox, Inc. Sees Opportunity in Several New States
6. Emerging Markets Present Challenge for Medical Device Companies Outsourcing Clinical Activities
7. Solid State Lighting Market worth $56.79 Billion by 2018
8. Hospital Acquired Infection Control Market: Sterilization, Disinfection, Testing and Treatment
9. Innophos To Present At 2013 KeyBanc Capital Markets Basic Materials & Packaging Conference
10. mHealth Apps & Solutions Market Worth $20.7 Billion by 2018
11. The Strongly Growing Chinese Heart Valve Market Has A Number Of Distinct Features That Will Challenge Competitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/26/2017)... NEW YORK , July 26, 2017 ... Annual Prix Galien USA Award ... honors, the Prix Galien Award recognizes outstanding biomedical and technology ... To qualify, each candidate must be ... the last five years and demonstrate tremendous potential to impact ...
(Date:7/24/2017)... 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... second quarter 2017 operating results on Monday, August 7, ... follow at 5:00 p.m. ET. ... a live broadcast of the conference call by dialing ... code 51641230 approximately 15 minutes prior to the call. ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... An inventor from Salisbury, N.C., ... haven’t yet seen an effective and dignified way to keep leeches in place during ... CUP." , This invention provides an effective way to keep a leech in place ...
(Date:7/26/2017)... ... July 26, 2017 , ... A major challenge many labs ... freeze drying samples and a lengthy freeze dry cycle are a few common challenges ... drying techniques, as well as new accessories and advancements in laboratory freeze dryers that ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... the cloud ; today announced the availability of its latest data protection solution ... use control console for Data Discovery, Classification, Encryption and Digital Rights Management; GTB ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... or “Isodiol”) a global cannabis innovator, specializing in the development of pharmaceutical and ... from April 1, 2017 to June 30, 2017. Iso International LLC recorded unaudited ...
(Date:7/25/2017)... St. Louis, MO (PRWEB) , ... July 25, 2017 , ... ... (HDIS) in St. Louis, Missouri. The company has achieved record-breaking sales for ... multiple departments over the next 12 months. , The upcoming year offers excitement and ...
Breaking Medicine News(10 mins):